跳至主要内容
临床试验/NL-OMON21795
NL-OMON21795招募中不适用

Development and clinical activity of low dose metronomic chemotherapy with oral paclitaxel.

The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with histological or cytological proof of cancer who might benefit from treatment with paclitaxel (excluding patients with secondary breast cancer metastasis with only lung metastases and primary brain tumors);
  • 2. Patients for whom no standard therapy of proven benefit exist;

排除标准

  • 1. Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amenable for adequate follow up;
  • 2. Women who are pregnant or breast feeding;

研究者

发起方
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital

相似试验